阿尔茨海默病的回顾:过去,现在和未来

Jessy Rayathala, K. C, V. P
{"title":"阿尔茨海默病的回顾:过去,现在和未来","authors":"Jessy Rayathala, K. C, V. P","doi":"10.37022/jiaps.v7i1.274","DOIUrl":null,"url":null,"abstract":"Alzheimer’s disease is a progressive neurodegenerative disorders that is the six leading Cause of death and the most common cause of dementia worldwide. The most common cause of dementia is Alzheimer’s disease (AD). Accounting for nearly 60 to 80 % of all cases. AD is the six leading cause of death with an estimated prevalence of nearly 30 million people worldwide. Age is the most important risk factor for AD, with an exponential increase in prevalence from 3 to 32 % from the ages 65 to 85 years old. An estimated 5.6 million individuals over the age of 65 suffer from AD in the United States, a number projected to nearly triple to 13.8 million by 2050 due to increase in population. The 2000s ushered in a focus on the study of prodromal stages of neurodegerative disease before the full – blown dementia syndrome. The current decades have been the rise of imaging and other biomarkers to characterize preclinical disease before the development of significant cognitive decline. Finally, we suggest future directions and predictions for dementia related research and potential therapeutic interventions.","PeriodicalId":151037,"journal":{"name":"Journal of Innovations in Applied Pharmaceutical Science (JIAPS)","volume":"205 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Review on Alzheimer’s disease: past, present and future\",\"authors\":\"Jessy Rayathala, K. C, V. P\",\"doi\":\"10.37022/jiaps.v7i1.274\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Alzheimer’s disease is a progressive neurodegenerative disorders that is the six leading Cause of death and the most common cause of dementia worldwide. The most common cause of dementia is Alzheimer’s disease (AD). Accounting for nearly 60 to 80 % of all cases. AD is the six leading cause of death with an estimated prevalence of nearly 30 million people worldwide. Age is the most important risk factor for AD, with an exponential increase in prevalence from 3 to 32 % from the ages 65 to 85 years old. An estimated 5.6 million individuals over the age of 65 suffer from AD in the United States, a number projected to nearly triple to 13.8 million by 2050 due to increase in population. The 2000s ushered in a focus on the study of prodromal stages of neurodegerative disease before the full – blown dementia syndrome. The current decades have been the rise of imaging and other biomarkers to characterize preclinical disease before the development of significant cognitive decline. Finally, we suggest future directions and predictions for dementia related research and potential therapeutic interventions.\",\"PeriodicalId\":151037,\"journal\":{\"name\":\"Journal of Innovations in Applied Pharmaceutical Science (JIAPS)\",\"volume\":\"205 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Innovations in Applied Pharmaceutical Science (JIAPS)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37022/jiaps.v7i1.274\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Innovations in Applied Pharmaceutical Science (JIAPS)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37022/jiaps.v7i1.274","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

摘要

阿尔茨海默病是一种进行性神经退行性疾病,是全球六大主要死亡原因,也是痴呆症的最常见原因。老年痴呆症最常见的病因是阿尔茨海默病(AD)。占所有病例的近60%至80%。阿尔茨海默病是导致死亡的六大主要原因,据估计全世界有近3000万人患此病。年龄是阿尔茨海默病最重要的危险因素,从65岁到85岁,患病率呈指数增长,从3%增加到32%。在美国,估计有560万65岁以上的人患有阿尔茨海默病,由于人口的增加,到2050年,这一数字预计将增加近两倍,达到1380万。21世纪初,人们开始关注神经退行性疾病的前驱期,而不是全面发展的痴呆综合征。近几十年来,影像学和其他生物标志物的兴起使得临床前疾病在认知能力显著下降之前得到了表征。最后,我们提出了痴呆相关研究的未来方向和预测以及潜在的治疗干预措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Review on Alzheimer’s disease: past, present and future
Alzheimer’s disease is a progressive neurodegenerative disorders that is the six leading Cause of death and the most common cause of dementia worldwide. The most common cause of dementia is Alzheimer’s disease (AD). Accounting for nearly 60 to 80 % of all cases. AD is the six leading cause of death with an estimated prevalence of nearly 30 million people worldwide. Age is the most important risk factor for AD, with an exponential increase in prevalence from 3 to 32 % from the ages 65 to 85 years old. An estimated 5.6 million individuals over the age of 65 suffer from AD in the United States, a number projected to nearly triple to 13.8 million by 2050 due to increase in population. The 2000s ushered in a focus on the study of prodromal stages of neurodegerative disease before the full – blown dementia syndrome. The current decades have been the rise of imaging and other biomarkers to characterize preclinical disease before the development of significant cognitive decline. Finally, we suggest future directions and predictions for dementia related research and potential therapeutic interventions.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信